(Date:11/24/2009)...4 /PRNewswire-Asia/ -- NOD Pharmaceuticals Inc. an... has allowed the patent application for,its nano-p... NOD technology is a highly efficient approach to...e nano-particles to enable oral delivery of drugs,...gy is a platform technology,that can be applied to...
(Date:11/24/2009)...swire/ -- Blue Marble Energy Corp. announced today...t Authority (OPDA) were recently awarded $2 millio...ization Board (CERB) in a private/public partnersh...mical biorefinery in Lincoln County, WA. ,, "...opment of our biorefinery and bring over 70 green ...
(Date:11/24/2009)..., TORONTO, Nov. 24 /PRNewswire-FirstCall/ - Hamilt...tal Inc., a leading provider of advanced laser sys...d fertility clinic markets, today reported operati...nded September 30, 2009. , , Q3 2009 Highlight... $1.43 million in Q3 2008, - Gross profit mar...
(Date:11/24/2009)... Nov. 24 Genomic Health,...Scott, Genomic Health,s Executive Chairman, will p...e Conference in New York City on Tuesday, December...ve and subsequently archived webcast of the presen...nomic Health,s website at http://investor.genomic...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10Genomic Health to Present at Piper Jaffray Health Care Conference 2(Date:11/25/2009)... The FDA granted traditional approv...-nucleoside reverse transcriptase inhibitor (NNRTI...ted for use in treatment-experienced adults who ar...s resistant to an NNRTI and other antiretroviral (... 48-week data from two Phase 3 studies known as DU...
(Date:11/25/2009)... 25 Regado Biosciences, a privatel...mbotic aptamers with active control agents, announ... be presenting at the Piper Jaffray 21st Annual He...in New York City. Dr. Mazzo,s presentation will b... will include an overview of the Company,s pipelin...
(Date:11/25/2009)... Abaxis, Inc. (Nasdaq: ...oint-of-care blood analysis systems, announced tod...ve officer, will present at the 21st Annual Piper ...ber 2, 2009 at 2:00 p.m. ET. The conference will b...ty. ,, About Abaxis ,, Abaxis develops, m...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2New synthetic molecules trigger immune response to HIV and prostate cancer 10644 1New synthetic molecules trigger immune response to HIV and prostate cancer 10644 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 1Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 2Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 3Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 4Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 5Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 6Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results 60787 7Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 1Imagenetix to Present at 2nd Annual LD MICRO Conference at the Luxe Sunset Bel Air 14742 2